Patents by Inventor Heather Myers

Heather Myers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240180466
    Abstract: A computing system receives a plurality of customized three-dimensional image-caption pairs generated by an administrator. Each customized three-dimensional image-caption pair may be assigned a plurality of traits to each of the plurality of customized three-dimensional image-caption pairs. For each customized three-dimensional image-caption pair, the computing system scores each trait of the plurality of traits. The computing system deploys a personality assessment. The personality assessment includes the plurality of customized three-dimensional image-caption pairs. For each customized three-dimensional image-caption pair, the computing system receives response data from a test-taker. The response data includes an indication of whether the test-taker relates to the customized three-dimensional image-caption pair. Based on the response data, the computing system categorizes the test-taker into a personality dimension or personality type.
    Type: Application
    Filed: November 29, 2023
    Publication date: June 6, 2024
    Applicant: Paradox, Inc.
    Inventors: Justin Marshall, Scott Tremper, Dave Volpe, Heather Myers, Mark Parkinson, Rachel Stewart Johnson, Daniel Sines, Joshua Spears
  • Publication number: 20240066574
    Abstract: A waste disposal system for receiving pharmaceutical waste material including at least one of a solid phase pharmaceutical waste material and a liquid phase pharmaceutical waste material is provided. The waste receiver includes a receiver body defining an opening. The waster receiver further includes an inner surface defining a container volume in fluid communication with the opening, and an outer surface opposite the inner surface. The outer surface defines a lock passageway separate from the opening. The system further includes a bracket adapted to be secured to a fixed surface and a locking assembly coupled to the bracket and adapted to releasably secure the waste receiver to the fixed surface. The locking assembly includes a lock housing sized to be removably positioned at least partially within the lock passageway.
    Type: Application
    Filed: November 3, 2023
    Publication date: February 29, 2024
    Applicant: Stryker Corporation
    Inventors: Brian James VanderWoude, David A. Maness, Bryan Matthew Ulmer, Dennis Meyer, Lucas Wade, Stephen Myers, Logan Castillo, Heather Benoit
  • Patent number: 7145057
    Abstract: Sustained cultures of avian embryonic stem cells are provided. Injection of avian embryonic stem cells into recipient embryos yields chimeras with a significant contribution from the embryonic stem cell phenotype. Transgene encoding exogenous proteins are stably integrated in the embryonic stem cells and are present in the somatic tissue of the resulting chimeras. The transgenes may encode exogenous proteins expressed in endodermal, ectodermal, mesodermal, or extra embryonic tissue. Breeding the resulting chimera yields transgenic birds whose genome is comprised of exogenous DNA.
    Type: Grant
    Filed: February 1, 2002
    Date of Patent: December 5, 2006
    Assignee: Origen Therapeutics, Inc.
    Inventors: Marie-Cecile Van de Lavoir, Robert J. Etches, Babette Heyer, Jennifer Diamond, Christine Mather, Kathleen Beemer, Heather Myers
  • Publication number: 20030170888
    Abstract: Sustained cultures of avian embryonic stem cells are provided. Injection of avian embryonic stem cells into recipient embryos yields chimeras with a significant contribution from the embryonic stem cell phenotype. Transgene encoding exogenous proteins are stably integrated in the embryonic stem cells and are present in the somatic tissue of the resulting chimeras. The transgenes may encode exogenous proteins expressed in endodermal, ectodermal, mesodermal, or extra embryonic tissue. Breeding the resulting chimera yields transgenic birds whose genome is comprised of exogenous DNA.
    Type: Application
    Filed: February 1, 2002
    Publication date: September 11, 2003
    Applicant: Origen Therapeutics
    Inventors: Marie-Cecile Van de Lavoir, Robert J. Etches, Babette Heyer, Jennifer Diamond, Christine Mather, Kathleen Beemer, Heather Myers